MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy.

Jiachen WangZhen ShangJue WangJinhuan XuWeigang LiYuqi GuanLi YangWei ZhangKefeng ShenMeilan ZhangJin WangLiting ChenQinlu LiCheng HeNa WangLiang HuangYi XiaoMin XiaoJianfeng Zhou

Published in: Journal for immunotherapy of cancer (2021)

Keyphrases

high grade
low grade
diffuse large b cell lymphoma
cell therapy
transcription factor
stem cells